Aspen USA Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy (NCT04159493) | Aspen USA Inc | 2021-06-05 |
Track Aspen USA Inc automatically
Every clearance here is in the API, with alerts when new ones post.